annual CAPEX:
$2.21B+$5.00M(+0.23%)Summary
- As of today (April 18, 2025), ABT annual capital expenditures is $2.21 billion, with the most recent change of +$5.00 million (+0.23%) on December 31, 2024.
- During the last 3 years, ABT annual CAPEX has risen by +$322.00 million (+17.08%).
- ABT annual CAPEX is now at all-time high.
Performance
ABT CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$720.00M+$164.00M(+29.50%)Summary
- As of today (April 18, 2025), ABT quarterly capital expenditures is $720.00 million, with the most recent change of +$164.00 million (+29.50%) on December 31, 2024.
- Over the past year, ABT quarterly CAPEX has dropped by -$35.00 million (-4.64%).
- ABT quarterly CAPEX is now -23.92% below its all-time high of $946.40 million, reached on September 30, 1998.
Performance
ABT quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$2.21B-$35.00M(-1.56%)Summary
- As of today (April 18, 2025), ABT TTM capital expenditures is $2.21 billion, with the most recent change of -$35.00 million (-1.56%) on December 31, 2024.
- Over the past year, ABT TTM CAPEX has increased by +$5.00 million (+0.23%).
- ABT TTM CAPEX is now -1.74% below its all-time high of $2.25 billion, reached on June 30, 2024.
Performance
ABT TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ABT CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +0.2% | -4.6% | +0.2% |
| 3 y3 years | +17.1% | -4.6% | +0.2% |
| 5 y5 years | +34.7% | -4.6% | +0.2% |
ABT CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +24.2% | -4.6% | +124.3% | -1.7% | +24.3% |
| 5 y | 5-year | at high | +34.7% | -4.6% | +124.3% | -1.7% | +32.7% |
| alltime | all time | at high | +285.1% | -23.9% | +203.3% | -1.7% | >+9999.0% |
Abbott Laboratories CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $2.21B(+0.2%) | $720.00M(+29.5%) | $2.21B(-1.6%) |
| Sep 2024 | - | $556.00M(+4.3%) | $2.24B(-0.2%) |
| Jun 2024 | - | $533.00M(+33.9%) | $2.25B(+1.2%) |
| Mar 2024 | - | $398.00M(-47.3%) | $2.22B(+0.8%) |
| Dec 2023 | $2.20B(+23.9%) | $755.00M(+34.8%) | $2.20B(+7.0%) |
| Sep 2023 | - | $560.00M(+10.5%) | $2.06B(+4.7%) |
| Jun 2023 | - | $507.00M(+33.4%) | $1.96B(+7.0%) |
| Mar 2023 | - | $380.00M(-37.7%) | $1.84B(+3.3%) |
| Dec 2022 | $1.78B(-5.7%) | $610.00M(+30.6%) | $1.78B(-0.2%) |
| Sep 2022 | - | $467.00M(+23.2%) | $1.78B(+0.3%) |
| Jun 2022 | - | $379.00M(+18.1%) | $1.77B(-1.9%) |
| Mar 2022 | - | $321.00M(-47.7%) | $1.81B(-4.0%) |
| Dec 2021 | $1.89B(-13.4%) | $614.00M(+33.2%) | $1.89B(-3.3%) |
| Sep 2021 | - | $461.00M(+11.6%) | $1.95B(-1.8%) |
| Jun 2021 | - | $413.00M(+4.0%) | $1.99B(-10.3%) |
| Mar 2021 | - | $397.00M(-41.5%) | $2.21B(+1.7%) |
| Dec 2020 | $2.18B(+32.9%) | $679.00M(+36.9%) | $2.18B(+12.7%) |
| Sep 2020 | - | $496.00M(-22.7%) | $1.93B(+5.2%) |
| Jun 2020 | - | $642.00M(+78.3%) | $1.84B(+10.5%) |
| Mar 2020 | - | $360.00M(-17.1%) | $1.66B(+1.5%) |
| Dec 2019 | $1.64B(+17.5%) | $434.00M(+8.2%) | $1.64B(-2.0%) |
| Sep 2019 | - | $401.00M(-14.3%) | $1.67B(+2.9%) |
| Jun 2019 | - | $468.00M(+39.7%) | $1.62B(+11.7%) |
| Mar 2019 | - | $335.00M(-28.3%) | $1.45B(+4.3%) |
| Dec 2018 | $1.39B(+22.8%) | $467.00M(+31.9%) | $1.39B(+9.6%) |
| Sep 2018 | - | $354.00M(+18.8%) | $1.27B(+7.7%) |
| Jun 2018 | - | $298.00M(+8.4%) | $1.18B(+3.8%) |
| Mar 2018 | - | $275.00M(-20.3%) | $1.14B(+0.3%) |
| Dec 2017 | $1.14B(+1.2%) | $345.00M(+31.2%) | $1.14B(+2.3%) |
| Sep 2017 | - | $263.00M(+3.1%) | $1.11B(-4.2%) |
| Jun 2017 | - | $255.00M(-6.3%) | $1.16B(+0.7%) |
| Mar 2017 | - | $272.00M(-14.7%) | $1.15B(+2.6%) |
| Dec 2016 | $1.12B(+1.0%) | $319.00M(+2.2%) | $1.12B(+6.8%) |
| Sep 2016 | - | $312.00M(+26.3%) | $1.05B(-8.6%) |
| Jun 2016 | - | $247.00M(+1.6%) | $1.15B(+2.8%) |
| Mar 2016 | - | $243.00M(-2.0%) | $1.12B(+0.7%) |
| Dec 2015 | $1.11B(+3.1%) | $248.00M(-39.7%) | $1.11B(-3.4%) |
| Sep 2015 | - | $411.00M(+90.3%) | $1.15B(+13.2%) |
| Jun 2015 | - | $216.00M(-8.1%) | $1.01B(-4.0%) |
| Mar 2015 | - | $235.00M(-18.1%) | $1.06B(-1.9%) |
| Dec 2014 | $1.08B(-5.9%) | $287.00M(+3.6%) | $1.08B(-1.5%) |
| Sep 2014 | - | $277.00M(+7.4%) | $1.09B(0.0%) |
| Jun 2014 | - | $258.00M(+1.2%) | $1.09B(-2.9%) |
| Mar 2014 | - | $255.00M(-15.8%) | $1.13B(-1.7%) |
| Dec 2013 | $1.15B(-36.2%) | $303.00M(+9.4%) | $1.15B(-6.7%) |
| Sep 2013 | - | $277.00M(-4.8%) | $1.23B(-17.1%) |
| Jun 2013 | - | $291.00M(+6.2%) | $1.48B(-8.3%) |
| Mar 2013 | - | $274.00M(-29.0%) | $1.62B(-10.0%) |
| Dec 2012 | $1.79B(+20.4%) | $385.81M(-27.3%) | $1.79B(+6.6%) |
| Sep 2012 | - | $530.75M(+24.8%) | $1.68B(+4.9%) |
| Jun 2012 | - | $425.12M(-6.2%) | $1.60B(+3.4%) |
| Mar 2012 | - | $453.33M(+65.3%) | $1.55B(+4.1%) |
| Dec 2011 | $1.49B(+46.9%) | $274.24M(-39.3%) | $1.49B(-1.1%) |
| Sep 2011 | - | $452.00M(+21.2%) | $1.51B(+19.6%) |
| Jun 2011 | - | $372.96M(-4.8%) | $1.26B(+8.6%) |
| Mar 2011 | - | $391.81M(+34.5%) | $1.16B(+14.4%) |
| Dec 2010 | $1.02B(-6.8%) | $291.33M(+42.1%) | $1.02B(+4.7%) |
| Sep 2010 | - | $205.09M(-25.0%) | $969.19M(-11.3%) |
| Jun 2010 | - | $273.51M(+11.6%) | $1.09B(+1.0%) |
| Mar 2010 | - | $245.14M(-0.1%) | $1.08B(-0.6%) |
| Dec 2009 | $1.09B(-15.4%) | $245.45M(-25.3%) | $1.09B(-1.7%) |
| Sep 2009 | - | $328.71M(+25.1%) | $1.11B(+0.8%) |
| Jun 2009 | - | $262.74M(+4.2%) | $1.10B(-8.9%) |
| Mar 2009 | - | $252.15M(-4.7%) | $1.21B(-6.3%) |
| Dec 2008 | $1.29B | $264.59M(-17.3%) | $1.29B(-11.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2008 | - | $319.81M(-13.6%) | $1.45B(-4.5%) |
| Jun 2008 | - | $370.34M(+11.2%) | $1.52B(-8.5%) |
| Mar 2008 | - | $332.98M(-22.3%) | $1.66B(+0.2%) |
| Dec 2007 | $1.66B(+23.8%) | $428.78M(+10.6%) | $1.66B(+7.4%) |
| Sep 2007 | - | $387.58M(-24.1%) | $1.54B(+2.3%) |
| Jun 2007 | - | $510.73M(+55.2%) | $1.51B(+9.9%) |
| Mar 2007 | - | $329.12M(+4.8%) | $1.37B(+2.5%) |
| Dec 2006 | $1.34B(+10.8%) | $314.12M(-10.8%) | $1.34B(+0.2%) |
| Sep 2006 | - | $352.34M(-6.1%) | $1.34B(+7.3%) |
| Jun 2006 | - | $375.11M(+26.6%) | $1.24B(+6.4%) |
| Mar 2006 | - | $296.25M(-4.9%) | $1.17B(-3.1%) |
| Dec 2005 | $1.21B(-6.5%) | $311.65M(+19.0%) | $1.21B(-3.7%) |
| Sep 2005 | - | $261.99M(-12.6%) | $1.25B(-8.1%) |
| Jun 2005 | - | $299.71M(-10.3%) | $1.36B(+3.2%) |
| Mar 2005 | - | $334.14M(-6.6%) | $1.32B(+2.3%) |
| Dec 2004 | $1.29B(+23.0%) | $357.93M(-3.8%) | $1.29B(+9.8%) |
| Sep 2004 | - | $371.92M(+44.6%) | $1.18B(+8.0%) |
| Jun 2004 | - | $257.29M(-15.5%) | $1.09B(+1.8%) |
| Mar 2004 | - | $304.49M(+25.5%) | $1.07B(+1.9%) |
| Dec 2003 | $1.05B(-5.0%) | $242.53M(-14.9%) | $1.05B(+4.7%) |
| Sep 2003 | - | $284.90M(+19.8%) | $1.00B(-2.4%) |
| Jun 2003 | - | $237.72M(-16.6%) | $1.03B(-3.6%) |
| Mar 2003 | - | $284.91M(+45.9%) | $1.07B(-3.6%) |
| Dec 2002 | $1.11B(-5.0%) | $195.34M(-36.9%) | $1.11B(-13.1%) |
| Sep 2002 | - | $309.62M(+12.4%) | $1.27B(-7.3%) |
| Jun 2002 | - | $275.57M(-15.2%) | $1.37B(+9.7%) |
| Mar 2002 | - | $324.91M(-10.3%) | $1.25B(+7.6%) |
| Dec 2001 | $1.16B(+12.3%) | $362.10M(-11.7%) | $1.16B(+4.9%) |
| Sep 2001 | - | $410.22M(+165.3%) | $1.11B(+23.7%) |
| Jun 2001 | - | $154.62M(-34.7%) | $896.42M(-13.0%) |
| Mar 2001 | - | $236.77M(-23.0%) | $1.03B(-0.5%) |
| Dec 2000 | $1.04B(-14.0%) | $307.63M(+55.8%) | $1.04B(-13.8%) |
| Sep 2000 | - | $197.40M(-31.7%) | $1.20B(-5.3%) |
| Jun 2000 | - | $289.04M(+19.5%) | $1.27B(+2.9%) |
| Mar 2000 | - | $241.80M(-49.0%) | $1.23B(+2.5%) |
| Dec 1999 | $1.20B(-3.1%) | $473.88M(+78.7%) | $1.20B(+17.3%) |
| Sep 1999 | - | $265.12M(+4.7%) | $1.03B(-39.9%) |
| Jun 1999 | - | $253.19M(+19.5%) | $1.71B(+40.4%) |
| Mar 1999 | - | $211.91M(-28.5%) | $1.22B(-2.1%) |
| Dec 1998 | $1.24B(+2.7%) | $296.30M(-68.7%) | $1.24B(-12.7%) |
| Sep 1998 | - | $946.40M(-497.0%) | $1.42B(+17.7%) |
| Jun 1998 | - | -$238.40M(-200.0%) | $1.21B(-16.5%) |
| Mar 1998 | - | $238.40M(-50.0%) | $1.45B(+19.7%) |
| Dec 1997 | $1.21B(+27.5%) | $477.20M(-34.8%) | $1.21B(+21.0%) |
| Sep 1997 | - | $732.40M(+173.9%) | $999.83M(+5.4%) |
| Dec 1996 | $949.00M(-5.8%) | $267.43M(+21.2%) | $949.00M(+39.2%) |
| Sep 1996 | - | $220.67M(-4.5%) | $681.57M(+47.9%) |
| Jun 1996 | - | $231.10M(+0.6%) | $460.90M(+100.6%) |
| Mar 1996 | - | $229.80M(-133.0%) | $229.80M(>+9900.0%) |
| Dec 1993 | - | -$697.00M(-385.5%) | $0.00(-100.0%) |
| Sep 1993 | - | $244.10M(+1.2%) | $1.00B(-0.5%) |
| Jun 1993 | - | $241.10M(+13.8%) | $1.01B(+0.5%) |
| Mar 1993 | - | $211.80M(-30.6%) | $1.00B(-0.5%) |
| Dec 1992 | $1.01B(+30.7%) | $305.40M(+22.8%) | $1.01B(+3.6%) |
| Sep 1992 | - | $248.70M(+5.2%) | $972.60M(+7.4%) |
| Jun 1992 | - | $236.30M(+9.0%) | $905.40M(+8.7%) |
| Mar 1992 | - | $216.80M(-19.9%) | $833.00M(+8.1%) |
| Dec 1991 | $770.60M(+20.1%) | $270.80M(+49.2%) | $770.60M(+12.5%) |
| Sep 1991 | - | $181.50M(+10.7%) | $684.90M(+5.8%) |
| Jun 1991 | - | $163.90M(+6.2%) | $647.60M(+1.0%) |
| Mar 1991 | - | $154.40M(-16.6%) | $641.10M(-0.0%) |
| Dec 1990 | $641.40M(+11.9%) | $185.10M(+28.4%) | $641.40M(+40.6%) |
| Sep 1990 | - | $144.20M(-8.4%) | $456.30M(+46.2%) |
| Jun 1990 | - | $157.40M(+1.7%) | $312.10M(+101.7%) |
| Mar 1990 | - | $154.70M | $154.70M |
| Dec 1989 | $573.10M | - | - |
FAQ
- What is Abbott Laboratories annual capital expenditures?
- What is the all time high annual CAPEX for Abbott Laboratories?
- What is Abbott Laboratories annual CAPEX year-on-year change?
- What is Abbott Laboratories quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Abbott Laboratories?
- What is Abbott Laboratories quarterly CAPEX year-on-year change?
- What is Abbott Laboratories TTM capital expenditures?
- What is the all time high TTM CAPEX for Abbott Laboratories?
- What is Abbott Laboratories TTM CAPEX year-on-year change?
What is Abbott Laboratories annual capital expenditures?
The current annual CAPEX of ABT is $2.21B
What is the all time high annual CAPEX for Abbott Laboratories?
Abbott Laboratories all-time high annual capital expenditures is $2.21B
What is Abbott Laboratories annual CAPEX year-on-year change?
Over the past year, ABT annual capital expenditures has changed by +$5.00M (+0.23%)
What is Abbott Laboratories quarterly capital expenditures?
The current quarterly CAPEX of ABT is $720.00M
What is the all time high quarterly CAPEX for Abbott Laboratories?
Abbott Laboratories all-time high quarterly capital expenditures is $946.40M
What is Abbott Laboratories quarterly CAPEX year-on-year change?
Over the past year, ABT quarterly capital expenditures has changed by -$35.00M (-4.64%)
What is Abbott Laboratories TTM capital expenditures?
The current TTM CAPEX of ABT is $2.21B
What is the all time high TTM CAPEX for Abbott Laboratories?
Abbott Laboratories all-time high TTM capital expenditures is $2.25B
What is Abbott Laboratories TTM CAPEX year-on-year change?
Over the past year, ABT TTM capital expenditures has changed by +$5.00M (+0.23%)